(Q35064294)

6 August 2017

1 reference

title

The ideal characteristics of antiepileptic therapy: an overview of old and new AEDs (English)

1 reference

6 August 2017

4

Nakken KO

1 reference

6 August 2017

Steinhoff BJ

1

1 reference

6 August 2017

Hirsch E

series ordinal

2

1 reference

6 August 2017

Mutani R

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Acta Neurologica Scandinavica

6 August 2017

published in

1 reference

6 August 2017

volume

107

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

87-95

1 reference

A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Topography of interictal glucose hypometabolism in unilateral mesiotemporal epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Transcranial magnetic stimulation: its current role in epilepsy research

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

When antiepileptic drugs aggravate epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Therapeutic monitoring of the new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Sodium bromide: effects on different patterns of epileptiform activity, extracellular pH changes and GABAergic inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Human brain GABA levels rise rapidly after initiation of vigabatrin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Myoclonus and epilepsy in childhood: 1996 Royaumont meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Epileptic negative myoclonus induced by carbamazepine in a child with BECTS. Benign childhood epilepsy with centrotemporal spikes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

"Baltic" myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Long-term treatment with vigabatrin - 10 years of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

Progression in mesial temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

The problem of intractability: the continuing need for new medical therapies in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Antiepileptic drug therapy: general treatment principles and application for special patient populations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

The management of epilepsy in the 1990s. Acquisitions, uncertainties and priorities for future research

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Low brain GABA level is associated with poor seizure control.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Combined measurements of hippocampal N-acetyl-aspartate and T2 relaxation time in the evaluation of mesial temporal lobe epilepsy: correlation with clinical severity and memory performances.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Myoclonus associated with the use of gabapentin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Nonconvulsive status epilepticus in two patients receiving tiagabine treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Primary Generalized Epilepsies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: an electroencephalographic study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Vigabatrin and multifocal myoclonus in adults with partial seizures

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

1 reference

7 January 2021

The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Vigabatrin and lamotrigine in refractory epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Dose Frequency and Dose Interval Compliance with Multiple Antiepileptic Medications During a Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Pharmacological problems in the management of epilepsy in children.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.01311.X

7 January 2021

10.1034/J.1600-0404.2003.01311.X

Identifiers

DOI

1 reference

6 August 2017

1 reference